Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia

ClinicalTrials.gov ID: NCT01114139

Public ClinicalTrials.gov record NCT01114139. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 4:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the efficacy and safety of intravenous (IV) ferumoxytol compared with placebo for the treatment of iron deficiency anemia (IDA).

Study identification

NCT ID
NCT01114139
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AMAG Pharmaceuticals, Inc.
Industry
Enrollment
812 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 19, 2010 (Actual)
Primary completion
Feb 27, 2012 (Actual)
Completion
Oct 22, 2012 (Actual)
Last update posted
Apr 21, 2022

2010 – 2012

United States locations

U.S. sites
137
U.S. states
32
U.S. cities
108
Facility City State ZIP Site status
Clinical Trial Site Birmingham Alabama — —
Clinical Trial Site Mobile Alabama — —
Clinical Trial Site Montgomery Alabama 36106 —
Clinical Trial Site Montgomery Alabama — —
Clinical Trial Site Green Valley Arizona — —
Clinical Trial Site Phoenix Arizona 85032 —
Clinical Trial Site Phoenix Arizona — —
Clinical Trial Site Tucson Arizona 85710 —
Clinical Trial Site Tucson Arizona — —
Clinical Trial Site Alhambra California — —
Clinical Trial Site Anaheim California — —
Clinical Trial Site Bakersfield California — —
Clinical Trial Site Buena Park California — —
Clinical Trial Site Colton California — —
Clinical Trial Site Fresno California — —
Clinical Trial Site Glendale California — —
Clinical Trial Site Laguna Hills California 92653 —
Clinical Trial Site Laguna Hills California — —
Clinical Trial Site Lakewood California — —
Clinical Trial Site Los Angeles California 90036 —
Clinical Trial Site Los Angeles California 90057 —
Clinical Trial Site Los Angeles California — —
Clinical Trial Site Mission Hills California — —
Clinical Trial Site Orange California — —
Clinical Trial Site San Diego California 92103 —
Clinical Trial Site San Diego California 92123 —
Clinical Trial Site San Diego California — —
Clinical Trial Site Pueblo Colorado — —
Clinical Trial Site Bristol Connecticut — —
Clinical Trial Site Groton Connecticut — —
Clinical Trial Site Newark Delaware — —
Clinical Trial Site Boynton Beach Florida 33426 —
Clinical Trial Site Boynton Beach Florida — —
Clinical Trial Site Clearwater Florida 33759 —
Clinical Trial Site Clearwater Florida — —
Clinical Trial Site Hialeah Florida — —
Clinical Trial Site Holiday Florida — —
Clinical Trial Site Inverness Florida — —
Clinical Trial Site Margate Florida — —
Clinical Trial Site Miami Florida 33126 —
Clinical Trial Site Miami Florida 33143 —
Clinical Trial Site Miami Florida 33144 —
Clinical Trial Site Miami Florida 33175 —
Clinical Trial Site Miami Florida — —
Clinical Trial Site Miami Lakes Florida — —
Clinical Trial Site Naples Florida — —
Clinical Trial Site Ocala Florida — —
Clinical Trial Site Vero Beach Florida — —
Clinical Trial Site Wellington Florida 33414 —
Clinical Trial Site Wellington Florida — —
Clinical Trial Site West Palm Beach Florida — —
Clinical Trial Site Winter Park Florida — —
Clinical Trial Site Zephyrhills Florida — —
Clinical Trial Site Atlanta Georgia 30308 —
Clinical Trial Site Atlanta Georgia 30342 —
Clinical Trial Site Atlanta Georgia — —
Clinical Trial Site Columbus Georgia — —
Clinical Trial Site Decatur Georgia — —
Clinical Trial Site Dublin Georgia — —
Clinical Trial Site Rome Georgia — —
Clinical Trial Site Sandy Springs Georgia — —
Clinical Trial Site Savannah Georgia — —
Clinical Trial Site Stockbridge Georgia — —
Clinical Trial Site Aurora Illinois — —
Clinical Trial Site Chicago Illinois 60611 —
Clinical Trial Site Chicago Illinois — —
Clinical Trial Site Evergreen Park Illinois — —
Clinical Trial Site Skokie Illinois 60076 —
Clinical Trial Site Skokie Illinois — —
Clinical Trial Site Springfield Illinois — —
Clinical Trial Site Indianapolis Indiana — —
Clinical Trial Site Wichita Kansas — —
Clinical Trial Site New Orleans Louisiana — —
Clinical Trial Site Bethesda Maryland — —
Clinical Trial Site Hollywood Maryland — —
Clinical Trial Site Prince Frederick Maryland — —
AMAG Pharmaceuticals, Inc. Waltham Massachusetts 02451 —
Clinical Trial Site Bay City Michigan 48706 —
Clinical Trial Site Bay City Michigan — —
Clinical Trial Site Saginaw Michigan — —
Clinical Trial Site Wyoming Michigan — —
Clinical Trial Site Kansas City Missouri — —
Clinical Trial Site Las Vegas Nevada — —
Clinical Trial Site Lawrenceville New Jersey — —
Clinical Trial Site Neptune City New Jersey — —
Clinical Trial Site Plainsboro New Jersey — —
Clinical Trial Site Somerville New Jersey — —
Clinical Trial Site Voorhees Township New Jersey — —
Clinical Trial Site Albuquerque New Mexico — —
Clinical Trial Site Brooklyn New York — —
Clinical Trial Site Goshen New York — —
Clinical Trial Site New York New York 10038 —
Clinical Trial Site New York New York — —
Clinical Trial Site Raleigh North Carolina — —
Clinical Trial Site Wilmington North Carolina — —
Clinical Trial Site Winston-Salem North Carolina — —
Clinical Trial Site Bismarck North Dakota — —
Clinical Trial Site Akron Ohio — —
Clinical Trial Site Beavercreek Ohio — —
Clinical Trial Site Canton Ohio — —
Clinical Trial Site Carlisle Ohio — —
Clinical Trial Site Cincinnati Ohio 45202 —
Clinical Trial Site Cincinnati Ohio — —
Clinical Trial Site Columbus Ohio — —
Clinical Trial Site Dayton Ohio — —
Clinical Trial Site Marion Ohio 43302 —
Clinical Trial Site Marion Ohio — —
Clinical Trial Site Mentor Ohio — —
Clinical Trial Site Middletown Ohio — —
Clinical Trial Site Zanesville Ohio — —
Clinical Trial Site Norman Oklahoma — —
Clinical Trial Site Jenkintown Pennsylvania — —
Clinical Trial Site Levittown Pennsylvania — —
Clinical Trial Site East Providence Rhode Island — —
Clinical Trial Site Columbia South Carolina — —
Clinical Trial Site Greer South Carolina — —
Clinical Trial Site Myrtle Beach South Carolina — —
Clinical Trial Site North Charleston South Carolina — —
Clinical Trial Site Orangeburg South Carolina — —
Clinical Trial Site Rapid City South Dakota — —
Clinical Trial Site Nashville Tennessee — —
Clinical Trial Site Arlington Texas — —
Clinical Trial Site Dallas Texas — —
Clinical Trial Site Houston Texas 77030 —
Clinical Trial Site Houston Texas 77074 —
Clinical Trial Site Houston Texas — —
Clinical Trial Site Laredo Texas — —
Clinical Trial Site Longview Texas — —
Clinical Trial Site San Antonio Texas 78205 —
Clinical Trial Site San Antonio Texas 78209 —
Clinical Trial Site San Antonio Texas 78229 —
Clinical Trial Site San Antonio Texas 78258 —
Clinical Trial Site San Antonio Texas — —
Clinical Trial Site Spring Texas — —
Clinical Trial Site Orem Utah — —
Clinical Trial Site Chesapeake Virginia — —
Clinical Trial Site Norfolk Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01114139, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2022 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01114139 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →